Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | Axis |
| AUM | ₹1,534 Cr | ₹1,063 Cr |
| NAV | ₹38.9215 | ₹22.8900 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 6.8 years |
| Expense ratio | 1.1% | 1.8% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 27.90 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 1 month | — | +6.66% |
| 3 months | — | −0.17% |
| 6 months | — | +4.33% |
| YTD | — | −3.13% |
| 1 year | — | −3.09% |
| 3 years (CAGR) | — | +8.47% |
| 5 years (CAGR) | — | +5.41% |
| 10 years (CAGR) | — | — |
| Since launch | — | +12.87% |
Risk
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Volatility | — | 14.1% |
| Downside volatility | — | 10.3% |
| Sharpe | — | 0.14 |
| Sortino | — | 0.19 |
| Calmar | — | 0.48 |
| Return / risk | — | 0.60 |
| Deepest fall | — | −24.30% |
| Days to recover | — | 517 |
| Below its high | — | −7.66% |
Against benchmark
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Alpha | — | — |
| Beta | — | — |
| R² | — | — |
| Up capture | — | — |
| Down capture | — | — |
| Tracking error | — | — |
| Information ratio | — | — |
| Treynor | — | — |
Consistency
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Best 1-year | — | +70.80% |
| Middle 1-year | — | +9.41% |
| Worst 1-year | — | −16.36% |
| 1-year periods with a loss | — | 28.8% |
| Middle 3-year | — | +13.11% |
| Positive months | — | 63.9% |
| Best day | — | +3.71% |
| Worst day | — | −3.53% |
| Worst 5% day | — | −1.22% |
| Positive days | — | 52.6% |
| NAVs a year | — | 251 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| 5-year XIRR | — | +7.32% |
| 5-year value | — | ₹7,24,420 |
| 3-year XIRR | — | +3.16% |
| 1-year XIRR | — | +2.79% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 7% |
| Axis ESG Integration Strategy Fund Direct · filing Oct 2026 | 7% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and Axis ESG Integration Strategy Fund
Overlap
7.4%
smaller weight of each shared stock, added up
Stocks in common
4
of 39 and 40
Weight in common
15% · 7%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
| Common stock | Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | Counts toward overlap |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 7.89% | 2.77% | 2.77% |
| Biocon Limited | 2.23% | 2.29% | 2.23% |
| Anthem Biosciences Limited | 2.99% | 1.67% | 1.67% |
| Alkem Laboratories Limited | 1.40% | 0.73% | 0.73% |
| 4 stocks | 14.5% | 7.5% | 7.4% |
Only in Tata India Pharma & Healthcare Fund (35)
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Apollo Hospitals Enterprise Limited | 4.55% |
| Max Healthcare Institute Limited | 4.28% |
| Rainbow Childrens Medicare Limited | 4.02% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Natco Pharma Limited | 2.86% |
| FDC Limited | 2.69% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Navin Fluorine International Limited | 2.15% |
| Sanofi Consumer Healthcare India Limited | 1.99% |
| Ajanta Pharma Limited | 1.59% |
| Dr Agarwal's Health Care Ltd | 1.31% |
| Gillette India Limited | 1.25% |
| Nestle India Limited | 1.09% |
and 10 smaller holdings (5.7% of the fund).
Only in Axis ESG Integration Strategy Fund (36)
| Reliance Industries Limited | 8.36% |
| ICICI Bank Limited | 6.78% |
| Clean Max Enviro Energy Solutions Limited | 6.70% |
| Bajaj Finance Limited | 5.72% |
| Titan Company Limited | 5.07% |
| Axis Bank Limited | 3.79% |
| Shriram Finance Limited | 3.71% |
| PVR Inox Limited | 3.48% |
| Pidilite Industries Limited | 3.04% |
| Piramal Finance Limited | 2.80% |
| Coforge Limited | 2.80% |
| Bharat Heavy Electricals Limited | 2.24% |
| Varun Beverages Limited | 2.14% |
| Arvind Limited | 2.02% |
| Chalet Hotels Limited | 1.76% |
| Metropolis Healthcare Limited | 1.74% |
| TBO Tek Limited | 1.59% |
| CG Power and Industrial Solutions Limited | 1.59% |
| TD Power Systems Limited | 1.49% |
| Star Health And Allied Insurance Co Limited | 1.41% |
| Cummins India Limited | 1.39% |
| IPCA Laboratories Limited | 1.35% |
| Eicher Motors Limited | 1.22% |
| SBI Life Insurance Company Limited | 1.04% |
| National Stock Exchange Of India Limited | 1.01% |
and 11 smaller holdings (5.0% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | Axis ESG Integration Strategy Fund | |
|---|---|---|
| Large companies | 26.8% | 49.8% |
| Mid companies | 30.4% | 13.1% |
| Small companies | 40.2% | 21.2% |
| Top 10 holdings | 50.1% | 49.5% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Finance 13% |